乳腺恶性叶状肿瘤伴骨肉瘤分化1例
A Case of Malignant Phyllodes Tumor of the Breast with Osteosarcoma Differentiation
DOI: 10.12677/acm.2024.14102774, PDF,   
作者: 肖 乐：青岛大学医学部，山东 青岛；丛义滋, 林 骏, 高 歌, 乔广东*：青岛大学附属烟台毓璜顶医院乳腺外科，山东 烟台；刘 婧：青岛大学附属烟台毓璜顶医院病理科，山东 烟台
关键词: 乳腺叶状肿瘤；骨肉瘤；异源性分化；手术治疗；放疗；Phyllodes Tumor of the Breast； Osteosarcoma； Heterologous Differentiation； Surgical Treatment； Radiotherapy
摘要: 目的：该文旨在探讨乳腺恶性叶状肿瘤的临床表现、鉴别诊断及治疗现状。方法：对青岛大学附属烟台毓璜顶医院乳腺外科收治的1例乳腺恶性叶状肿瘤伴骨肉瘤分化的患者进行回顾性分析并复习相关文献。结果：乳腺恶性叶状肿瘤是一种含有腺上皮成分和间叶成分的双相性肿瘤，其发病率较低。针对乳腺恶性叶状肿瘤，尤其是伴有异源性分化者，应注意鉴别诊断，最终确诊依靠石蜡病理。手术为首选的治疗方法，且手术边缘的宽度与局部复发有关。
Abstract: Objective: The aim of this article is to investigate the clinical manifestations, differential diagnosis and treatment status of malignant phyllodes tumor of the breast. Methods: A case of malignant phyllodes tumor of the breast with osteosarcoma differentiation admitted to the Department of Breast Surgery of Affiliated Yantai Yuhuangding Hospital of Qingdao University was retrospectively analyzed and relevant studies were reviewed. Results: Malignant phyllodes tumors of the breast are biphasic neoplasms containing both epithelial and mesenchymal components, with a relatively low incidence. For malignant phyllodes tumors, particularly those exhibiting heterologous differentiation, careful differential diagnosis is essential, with definitive diagnosis relying on paraffin-embedded pathology. Surgical excision is the preferred treatment, and the width of surgical margins is closely associated with the risk of local recurrence.
文章引用：肖乐, 丛义滋, 刘婧, 林骏, 高歌, 乔广东. 乳腺恶性叶状肿瘤伴骨肉瘤分化1例[J]. 临床医学进展, 2024, 14(10): 1113-1119. https://doi.org/10.12677/acm.2024.14102774

参考文献

[1] Chaney, A.W., Pollack, A., Mcneese, M.D., Zagars, G.K., Pisters, P.W.T., Pollock, R.E., et al. (2000) Primary Treatment of Cystosarcoma Phyllodes of the Breast. Cancer, 89, 1502-1511. [Google Scholar] [CrossRef] 
[2] Parker, S.J. and Harries, S.A. (2001) Phyllodes Tumours. Postgraduate Medical Journal, 77, 428-435. [Google Scholar] [CrossRef] [PubMed]
[3] Kim, S., Kim, J., Kim, D.H., Jung, W.H. and Koo, J.S. (2013) Analysis of Phyllodes Tumor Recurrence According to the Histologic Grade. Breast Cancer Research and Treatment, 141, 353-363. [Google Scholar] [CrossRef] [PubMed]
[4] Soumarová, R., Šeneklová, Z., Horová, H., Vojkovská, H., Horová, I., Budíková, M., et al. (2004) Retrospective Analysis of 25 Women with Malignant Cystosarcoma Phyllodes—Treatment Results. Archives of Gynecology and Obstetrics, 269, 278-281. [Google Scholar] [CrossRef] [PubMed]
[5] Conner, J.R. and Hornick, J.L. (2013) SATB2 Is a Novel Marker of Osteoblastic Differentiation in Bone and Soft Tissue Tumours. Histopathology, 63, 36-49. [Google Scholar] [CrossRef] [PubMed]
[6] Hu, Q., Mei, X., Feng, Y., Ma, J., Yang, Z., Shao, Z., et al. (2016) Early Local Recurrence Presents Adverse Effect on Outcomes of Primary Breast Sarcoma: A Retrospective Study from Single Institute in China. Medicine, 95, e2422. [Google Scholar] [CrossRef] [PubMed]
[7] Dey, S. (2013) Primary Osteosarcoma of Breast, a Rare Case. Journal of Clinical and Diagnostic Research, 7, 1710-1711. [Google Scholar] [CrossRef] [PubMed]
[8] Pezzi, C.M., Patel-Parekh, L., Cole, K., Franko, J., Klimberg, V.S. and Bland, K. (2006) Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data Base. Annals of Surgical Oncology, 14, 166-173. [Google Scholar] [CrossRef] [PubMed]
[9] Koker, M.M. and Kleer, C.G. (2004) P63 Expression in Breast Cancer: A Highly Sensitive and Specific Marker of Metaplastic Carcinoma. American Journal of Surgical Pathology, 28, 1506-1512. [Google Scholar] [CrossRef] [PubMed]
[10] Leibl, S., Gogg-Kammerer, M., Sommersacher, A., Denk, H. and Moinfar, F. (2005) Metaplastic Breast Carcinomas: Are They of Myoepithelial Differentiation? Immunohistochemical Profile of the Sarcomatoid Subtype Using Novel Myoepithelial Markers. The American Journal of Surgical Pathology, 29, 347-353. [Google Scholar] [CrossRef] [PubMed]
[11] Esposito, N.N., Mohan, D., Brufsky, A., Lin, Y., Kapali, M. and Dabbs, D.J. (2006) Phyllodes Tumor: A Clinicopathologic and Immunohistochemical Study of 30 Cases. Archives of Pathology & Laboratory Medicine, 130, 1516-1521. [Google Scholar] [CrossRef] [PubMed]
[12] Tremblay-LeMay, R., Hogue, J., Provencher, L., Poirier, B., Poirier, É., Laberge, S., et al. (2016) How Wide Should Margins Be for Phyllodes Tumors of the Breast? The Breast Journal, 23, 315-322. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, W., Cheng, S., Tzen, C., Yang, T., Jeng, K., Liu, C., et al. (2005) Surgical Treatment of Phyllodes Tumors of the Breast: Retrospective Review of 172 Cases. Journal of Surgical Oncology, 91, 185-194. [Google Scholar] [CrossRef] [PubMed]
[14] Assi, H., Salem, R., Sukhon, F., Abbas, J., Boulos, F. and Saghir, N.E. (2018) Phyllodes Tumors of the Breast Treated in a Tertiary Health Care Center: Case Series and Literature Review. Journal of International Medical Research, 48, 1-10. [Google Scholar] [CrossRef] [PubMed]
[15] Warner, W.A., Sookdeo, V.D., Fortuné, M., Akhilesh, M., Rao Adidam Venkata, C., Mohammed, W., et al. (2017) Clinicopathology and Treatment of a Giant Malignant Phyllodes Tumor of the Breast: A Case Report and Literature Review. International Journal of Surgery Case Reports, 41, 259-264. [Google Scholar] [CrossRef] [PubMed]
[16] Sazuka, T., Matsuzaki, H., Kanada, Y., et al. (2015) A Case of Malignant Phyllodes Tumor Effectively Treated by Radiation Therapy as a Palliative Medicine. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 42, 1698-1699.
[17] Khan, S., Griffiths, E.A., Shah, N. and Ravi, S. (2008) Primary Osteogenic Sarcoma of the Breast: A Case Report. Cases Journal, 1, Article No. 148. [Google Scholar] [CrossRef] [PubMed]
[18] ESMO/European Sarcoma Network Working Group (2014) Bone Sarcomas: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 25, iii113-iii123.
[19] Longhi, A., Bielack, S.S., Grimer, R., Whelan, J., Windhager, R., Leithner, A., et al. (2017) Extraskeletal Osteosarcoma: A European Musculoskeletal Oncology Society Study on 266 Patients. European Journal of Cancer, 74, 9-16. [Google Scholar] [CrossRef] [PubMed]

为你推荐